drugset / Trial / NCT02655705

Comparison Study of Psoriasis Severity Assessment Tools

NCT02655705

Phase 4 Completed 34 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the performance of objective psoriasis severity assessment tool compared with a subjective assessment tool for the assessment of the improvement of psoriasis after oral cyclosporine A or methotrexate treatment.

Timeline

Start
2014-08
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 150 mg Oral
Comparator Cyclosporine Peptide 200 mg Oral
Comparator Methotrexate Small molecule 15 mg Oral

Indications